Literature DB >> 21432550

Abdominal circumference should not be a required criterion for the diagnosis of metabolic syndrome.

Kiyoshi Shibata1, Sadao Suzuki, Juichi Sato, Isao Ohsawa, Shinichi Goto, Masaru Hashiguchi, Shinkan Tokudome.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) is an established concept. However, it is characterized by a number of different definitions as well as different cut-off points (COPs) for waist circumference (WC) and different modes for incorporating WC into the diagnostic criteria.
METHODS: Abdominal ultrasonography was performed in 2,333 subjects who also underwent comprehensive medical examinations between April and July 2006. The odds ratios for the number of MetS components were calculated by taking central obesity status into account and considering concurrent fatty liver as an independent variable. We compared the areas under the receiver operating characteristic (ROC) curves for fatty liver and MetS using several MetS criteria.
RESULTS: Regardless of the WC criterion selected, we observed a strong linear trend for an association (trend P < 0.0001) between MetS and the number of components. The odds ratio (OR) of subjects without central obesity but with all three MetS components was 9.69 (95% confidence interval 3.11-30.2) in men and 55.3 (6.34-483) in women. The COP for the largest area under the curve in men and women was ≥82 cm (OR 0.701) and ≥77 cm (OR 0.699), respectively, when WC was considered as a component. When WC distribution is taken into consideration, practical and appropriate COPs should be ≥85 cm for men and ≥80 cm for women.
CONCLUSION: We suggest that a WC of ≥85 cm for men and ≥80 cm for women would be optimal COPs for the central obesity criteria in the Japanese population. In addition, central obesity should be incorporated as a component of MetS rather than an essential requirement for the diagnosis of MetS.

Entities:  

Year:  2010        PMID: 21432550      PMCID: PMC2886890          DOI: 10.1007/s12199-009-0132-7

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  25 in total

Review 1.  [What is 'metabolic domino effect'?--new concept in lifestyle-related diseases].

Authors:  Hiroshi Itoh
Journal:  Nihon Rinsho       Date:  2003-10

2.  A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population.

Authors:  Kazuo Hara; Yumi Matsushita; Momoko Horikoshi; Nobuo Yoshiike; Tetsuji Yokoyama; Heizo Tanaka; Takashi Kadowaki
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

3.  Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.

Authors:  S Goya Wannamethee; A Gerald Shaper; Lucy Lennon; Richard W Morris
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

4.  Echogenicity: analysis, significance, and masking.

Authors:  A B Kurtz; P A Dubbins; C S Rubin; R J Kurtz; H S Cooper; C Cole-Beuglet; B B Goldberg
Journal:  AJR Am J Roentgenol       Date:  1981-09       Impact factor: 3.959

5.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.

Authors:  Ann Marie McNeill; Wayne D Rosamond; Cynthia J Girman; Sherita Hill Golden; Maria I Schmidt; Honey E East; Christie M Ballantyne; Gerardo Heiss
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

6.  Optimal cutoff points of waist circumference for the criteria of abdominal obesity: comparison with the criteria of the International Diabetes Federation.

Authors:  Inkyung Baik
Journal:  Circ J       Date:  2009-08-28       Impact factor: 2.993

7.  Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.

Authors:  Robert S Lindsay; Deborah J Wake; Saraswathy Nair; Joy Bunt; Dawn E W Livingstone; Paska A Permana; P Antonio Tataranni; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.

Authors:  Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Hisatomi Arima; Michiaki Kubo; Yumihiro Tanizaki; Masanori Iwase; Mitsuo Iida; Yutaka Kiyohara
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

9.  Optimal cutoff point of waist circumference and use of home blood pressure as a definition of metabolic syndrome: the Ohasama study.

Authors:  Atsushi Sato; Kei Asayama; Takayoshi Ohkubo; Masahiro Kikuya; Taku Obara; Hirohito Metoki; Ryusuke Inoue; Azusa Hara; Haruhisa Hoshi; Junichiro Hashimoto; Kazuhito Totsune; Hiroshi Satoh; Yoshitomo Oka; Yutaka Imai
Journal:  Am J Hypertens       Date:  2008-03-06       Impact factor: 2.689

10.  Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.

Authors:  Earl S Ford; Matthias B Schulze; Tobias Pischon; Manuela M Bergmann; Hans-Georg Joost; Heiner Boeing
Journal:  Cardiovasc Diabetol       Date:  2008-12-12       Impact factor: 9.951

View more
  2 in total

1.  Needs survey on the priority given to periodical medical examination items among occupational physicians in Japan.

Authors:  Naoto Ito; Tomohisa Nagata; Masayuki Tatemichi; Toru Takebayashi; Koji Mori
Journal:  J Occup Health       Date:  2018-09-20       Impact factor: 2.708

2.  Metabolic Syndrome Components Are Associated with Intervertebral Disc Degeneration: The Wakayama Spine Study.

Authors:  Masatoshi Teraguchi; Noriko Yoshimura; Hiroshi Hashizume; Shigeyuki Muraki; Hiroshi Yamada; Hiroyuki Oka; Akihito Minamide; Yuyu Ishimoto; Keiji Nagata; Ryohei Kagotani; Sakae Tanaka; Hiroshi Kawaguchi; Kozo Nakamura; Toru Akune; Munehito Yoshida
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.